Digital Pathology, which also refers as virtual microscopy, incorporates capturing, sharing, managing, interpreting and analysing the digital information from a glass slide. Pathology is a study of disease whether caused by pathogens or non- infectious, physical disorder; it refers to the scientific study of disease processes; it occupies a vital role in all type of drug discoveries. Digital pathology technology is widely used in the scanners, software, communication systems and storage systems and helps in the improvement of operational efficiency, enhancing productivity, developments in treatment decisions and patient care. In the year 1990s principle of virtual microscopy is used in the life science areas, and in the year 2000 scientific community agreed the term digital pathology denote digitisation efforts in pathology and later digital pathology technology is used in the various kind of applications.
The global Digital Pathology market size was valued at US$ 857 million in 2023 and is forecast to a readjusted size of USD 1972 million by 2030 with a CAGR of 12.8% during review period.
Global Digital Pathology key players include Danaher, Hamamatsu Photonics, Roche, etc. Global top three manufacturers hold a share over 30%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share over 35 percent.
In terms of product, Digital IVD Devices is the largest segment, with a share over 35%. And in terms of application, the largest application is Hospital & Diagnostic Centers, followed by Pharma & Biotech Companies.
This report is a detailed and comprehensive analysis for global Digital Pathology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Digital Pathology market size and forecasts, in consumption value ($ Million), 2019-2030
Global Digital Pathology market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Digital Pathology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Digital Pathology market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Digital Pathology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Digital Pathology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Hamamatsu Photonics, Roche, Philips, Olympus, PerkinElmer, Sectra, Nikon, Definiens, 3DHISTECH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Digital Pathology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
Digital Pathology market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Whole Slide Imaging
Image Analysis-Informatics
Information Management System Storage & Communication
Digital IVD Devices
Others
麻豆原创 segment by Application
Pharma & Biotech Companies
Hospital & Diagnostic Centers
Educational Institutes
麻豆原创 segment by players, this report covers
Danaher
Hamamatsu Photonics
Roche
Philips
Olympus
PerkinElmer
Sectra
Nikon
Definiens
3DHISTECH
Visiopharm
Apollo Enterprise Imaging
Glencoe Software
Indica Labs
OptraSCAN
Objective Pathology
Digipath
Pathcore
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Digital Pathology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Pathology, with revenue, gross margin, and global market share of Digital Pathology from 2019 to 2024.
Chapter 3, the Digital Pathology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Digital Pathology market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Pathology.
Chapter 13, to describe Digital Pathology research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Digital Pathology by Type
1.3.1 Overview: Global Digital Pathology 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Digital Pathology Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Whole Slide Imaging
1.3.4 Image Analysis-Informatics
1.3.5 Information Management System Storage & Communication
1.3.6 Digital IVD Devices
1.3.7 Others
1.4 Global Digital Pathology 麻豆原创 by Application
1.4.1 Overview: Global Digital Pathology 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharma & Biotech Companies
1.4.3 Hospital & Diagnostic Centers
1.4.4 Educational Institutes
1.5 Global Digital Pathology 麻豆原创 Size & Forecast
1.6 Global Digital Pathology 麻豆原创 Size and Forecast by Region
1.6.1 Global Digital Pathology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Digital Pathology 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Digital Pathology 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Digital Pathology 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Digital Pathology 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Digital Pathology 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Digital Pathology 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Digital Pathology Product and Solutions
2.1.4 Danaher Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Hamamatsu Photonics
2.2.1 Hamamatsu Photonics Details
2.2.2 Hamamatsu Photonics Major Business
2.2.3 Hamamatsu Photonics Digital Pathology Product and Solutions
2.2.4 Hamamatsu Photonics Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Hamamatsu Photonics Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Digital Pathology Product and Solutions
2.3.4 Roche Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Roche Recent Developments and Future Plans
2.4 Philips
2.4.1 Philips Details
2.4.2 Philips Major Business
2.4.3 Philips Digital Pathology Product and Solutions
2.4.4 Philips Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Philips Recent Developments and Future Plans
2.5 Olympus
2.5.1 Olympus Details
2.5.2 Olympus Major Business
2.5.3 Olympus Digital Pathology Product and Solutions
2.5.4 Olympus Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Olympus Recent Developments and Future Plans
2.6 PerkinElmer
2.6.1 PerkinElmer Details
2.6.2 PerkinElmer Major Business
2.6.3 PerkinElmer Digital Pathology Product and Solutions
2.6.4 PerkinElmer Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 PerkinElmer Recent Developments and Future Plans
2.7 Sectra
2.7.1 Sectra Details
2.7.2 Sectra Major Business
2.7.3 Sectra Digital Pathology Product and Solutions
2.7.4 Sectra Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Sectra Recent Developments and Future Plans
2.8 Nikon
2.8.1 Nikon Details
2.8.2 Nikon Major Business
2.8.3 Nikon Digital Pathology Product and Solutions
2.8.4 Nikon Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Nikon Recent Developments and Future Plans
2.9 Definiens
2.9.1 Definiens Details
2.9.2 Definiens Major Business
2.9.3 Definiens Digital Pathology Product and Solutions
2.9.4 Definiens Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Definiens Recent Developments and Future Plans
2.10 3DHISTECH
2.10.1 3DHISTECH Details
2.10.2 3DHISTECH Major Business
2.10.3 3DHISTECH Digital Pathology Product and Solutions
2.10.4 3DHISTECH Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 3DHISTECH Recent Developments and Future Plans
2.11 Visiopharm
2.11.1 Visiopharm Details
2.11.2 Visiopharm Major Business
2.11.3 Visiopharm Digital Pathology Product and Solutions
2.11.4 Visiopharm Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Visiopharm Recent Developments and Future Plans
2.12 Apollo Enterprise Imaging
2.12.1 Apollo Enterprise Imaging Details
2.12.2 Apollo Enterprise Imaging Major Business
2.12.3 Apollo Enterprise Imaging Digital Pathology Product and Solutions
2.12.4 Apollo Enterprise Imaging Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Apollo Enterprise Imaging Recent Developments and Future Plans
2.13 Glencoe Software
2.13.1 Glencoe Software Details
2.13.2 Glencoe Software Major Business
2.13.3 Glencoe Software Digital Pathology Product and Solutions
2.13.4 Glencoe Software Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Glencoe Software Recent Developments and Future Plans
2.14 Indica Labs
2.14.1 Indica Labs Details
2.14.2 Indica Labs Major Business
2.14.3 Indica Labs Digital Pathology Product and Solutions
2.14.4 Indica Labs Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Indica Labs Recent Developments and Future Plans
2.15 OptraSCAN
2.15.1 OptraSCAN Details
2.15.2 OptraSCAN Major Business
2.15.3 OptraSCAN Digital Pathology Product and Solutions
2.15.4 OptraSCAN Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 OptraSCAN Recent Developments and Future Plans
2.16 Objective Pathology
2.16.1 Objective Pathology Details
2.16.2 Objective Pathology Major Business
2.16.3 Objective Pathology Digital Pathology Product and Solutions
2.16.4 Objective Pathology Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Objective Pathology Recent Developments and Future Plans
2.17 Digipath
2.17.1 Digipath Details
2.17.2 Digipath Major Business
2.17.3 Digipath Digital Pathology Product and Solutions
2.17.4 Digipath Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Digipath Recent Developments and Future Plans
2.18 Pathcore
2.18.1 Pathcore Details
2.18.2 Pathcore Major Business
2.18.3 Pathcore Digital Pathology Product and Solutions
2.18.4 Pathcore Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Pathcore Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Digital Pathology Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Digital Pathology by Company Revenue
3.2.2 Top 3 Digital Pathology Players 麻豆原创 Share in 2023
3.2.3 Top 6 Digital Pathology Players 麻豆原创 Share in 2023
3.3 Digital Pathology 麻豆原创: Overall Company Footprint Analysis
3.3.1 Digital Pathology 麻豆原创: Region Footprint
3.3.2 Digital Pathology 麻豆原创: Company Product Type Footprint
3.3.3 Digital Pathology 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Digital Pathology Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Digital Pathology 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Digital Pathology Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Digital Pathology 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Digital Pathology Consumption Value by Type (2019-2030)
6.2 North America Digital Pathology 麻豆原创 Size by Application (2019-2030)
6.3 North America Digital Pathology 麻豆原创 Size by Country
6.3.1 North America Digital Pathology Consumption Value by Country (2019-2030)
6.3.2 United States Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Digital Pathology Consumption Value by Type (2019-2030)
7.2 Europe Digital Pathology Consumption Value by Application (2019-2030)
7.3 Europe Digital Pathology 麻豆原创 Size by Country
7.3.1 Europe Digital Pathology Consumption Value by Country (2019-2030)
7.3.2 Germany Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Digital Pathology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Digital Pathology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Digital Pathology 麻豆原创 Size by Region
8.3.1 Asia-Pacific Digital Pathology Consumption Value by Region (2019-2030)
8.3.2 China Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Digital Pathology Consumption Value by Type (2019-2030)
9.2 South America Digital Pathology Consumption Value by Application (2019-2030)
9.3 South America Digital Pathology 麻豆原创 Size by Country
9.3.1 South America Digital Pathology Consumption Value by Country (2019-2030)
9.3.2 Brazil Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Digital Pathology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Digital Pathology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Digital Pathology 麻豆原创 Size by Country
10.3.1 Middle East & Africa Digital Pathology Consumption Value by Country (2019-2030)
10.3.2 Turkey Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Digital Pathology 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Digital Pathology 麻豆原创 Drivers
11.2 Digital Pathology 麻豆原创 Restraints
11.3 Digital Pathology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Digital Pathology Industry Chain
12.2 Digital Pathology Upstream Analysis
12.3 Digital Pathology Midstream Analysis
12.4 Digital Pathology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Danaher
Hamamatsu Photonics
Roche
Philips
Olympus
PerkinElmer
Sectra
Nikon
Definiens
3DHISTECH
Visiopharm
Apollo Enterprise Imaging
Glencoe Software
Indica Labs
OptraSCAN
Objective Pathology
Digipath
Pathcore
听
听
*If Applicable.
